These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 25071087)

  • 1. Mutual antagonism of Wilms' tumor 1 and β-catenin dictates podocyte health and disease.
    Zhou L; Li Y; He W; Zhou D; Tan RJ; Nie J; Hou FF; Liu Y
    J Am Soc Nephrol; 2015 Mar; 26(3):677-91. PubMed ID: 25071087
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MicroRNA-466o-3p mediates β-catenin-induced podocyte injury by targeting Wilms tumor 1.
    Chen Q; Chen J; Wang C; Chen X; Liu J; Zhou L; Liu Y
    FASEB J; 2020 Nov; 34(11):14424-14439. PubMed ID: 32888352
    [TBL] [Abstract][Full Text] [Related]  

  • 3. WT1 ameliorates podocyte injury via repression of EZH2/β-catenin pathway in diabetic nephropathy.
    Wan J; Hou X; Zhou Z; Geng J; Tian J; Bai X; Nie J
    Free Radic Biol Med; 2017 Jul; 108():280-299. PubMed ID: 28315733
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CMIP interacts with WT1 and targets it on the proteasome degradation pathway.
    Zhang SY; Fan Q; Moktefi A; Ory V; Audard V; Pawlak A; Ollero M; Sahali D; Henique C
    Clin Transl Med; 2021 Jul; 11(7):e460. PubMed ID: 34323419
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatocyte growth factor signaling ameliorates podocyte injury and proteinuria.
    Dai C; Saleem MA; Holzman LB; Mathieson P; Liu Y
    Kidney Int; 2010 Jun; 77(11):962-73. PubMed ID: 20375988
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Down-regulation of Wt1 activates Wnt/β-catenin signaling through modulating endocytic route of LRP6 in podocyte dysfunction in vitro.
    Jing Z; Wei-jie Y; Yi-Feng ZG
    Cell Signal; 2015 Sep; 27(9):1772-80. PubMed ID: 26049137
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Non-canonical Wnt/calcium signaling is protective against podocyte injury and glomerulosclerosis.
    Zhou D; Wang Y; Gui Y; Fu H; Zhou S; Wang Y; Bastacky SI; Stolz DB; Liu Y
    Kidney Int; 2022 Jul; 102(1):96-107. PubMed ID: 35341792
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Wnt/β-catenin signalling and podocyte dysfunction in proteinuric kidney disease.
    Zhou L; Liu Y
    Nat Rev Nephrol; 2015 Sep; 11(9):535-45. PubMed ID: 26055352
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CXCR4 induces podocyte injury and proteinuria by activating β-catenin signaling.
    Mo H; Ren Q; Song D; Xu B; Zhou D; Hong X; Hou FF; Zhou L; Liu Y
    Theranostics; 2022; 12(2):767-781. PubMed ID: 34976212
    [No Abstract]   [Full Text] [Related]  

  • 10. Wnt/beta-catenin signaling promotes podocyte dysfunction and albuminuria.
    Dai C; Stolz DB; Kiss LP; Monga SP; Holzman LB; Liu Y
    J Am Soc Nephrol; 2009 Sep; 20(9):1997-2008. PubMed ID: 19628668
    [TBL] [Abstract][Full Text] [Related]  

  • 11. β-arrestin-1 drives endothelin-1-mediated podocyte activation and sustains renal injury.
    Buelli S; Rosanò L; Gagliardini E; Corna D; Longaretti L; Pezzotta A; Perico L; Conti S; Rizzo P; Novelli R; Morigi M; Zoja C; Remuzzi G; Bagnato A; Benigni A
    J Am Soc Nephrol; 2014 Mar; 25(3):523-33. PubMed ID: 24371298
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of miRNA-671-5p in Mediating Wnt/β-Catenin-Triggered Podocyte Injury.
    Wang C; Liu J; Zhang X; Chen Q; Bai X; Hong X; Zhou L; Liu Y
    Front Pharmacol; 2021; 12():784489. PubMed ID: 35111054
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Blockade of Wnt/β-catenin signaling by paricalcitol ameliorates proteinuria and kidney injury.
    He W; Kang YS; Dai C; Liu Y
    J Am Soc Nephrol; 2011 Jan; 22(1):90-103. PubMed ID: 21030600
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Yes-associated protein regulates podocyte cell cycle re-entry and dedifferentiation in adriamycin-induced nephropathy.
    Xie K; Xu C; Zhang M; Wang M; Min L; Qian C; Wang Q; Ni Z; Mou S; Dai H; Pang H; Gu L
    Cell Death Dis; 2019 Dec; 10(12):915. PubMed ID: 31801948
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Murine Denys-Drash syndrome: evidence of podocyte de-differentiation and systemic mediation of glomerulosclerosis.
    Patek CE; Fleming S; Miles CG; Bellamy CO; Ladomery M; Spraggon L; Mullins J; Hastie ND; Hooper ML
    Hum Mol Genet; 2003 Sep; 12(18):2379-94. PubMed ID: 12915483
    [TBL] [Abstract][Full Text] [Related]  

  • 16. AF1q Contributes to Adriamycin-Induced Podocyte Injury by Activating Wnt/β-Catenin Signaling.
    Zhang H; Ren R; Du J; Sun T; Wang P; Kang P
    Kidney Blood Press Res; 2017; 42(5):794-803. PubMed ID: 29069662
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNA-206 and its down-regulation of Wilms'Tumor-1 dictate podocyte health in adriamycin-induced nephropathy.
    Guo N; Guo J; Su D
    Ren Fail; 2016 Jul; 38(6):989-95. PubMed ID: 27056206
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sirtuin 6 protects against podocyte injury by blocking the renin-angiotensin system by inhibiting the Wnt1/β-catenin pathway.
    Miao H; Wang YN; Su W; Zou L; Zhuang SG; Yu XY; Liu F; Zhao YY
    Acta Pharmacol Sin; 2024 Jan; 45(1):137-149. PubMed ID: 37640899
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Wnt/β-catenin links oxidative stress to podocyte injury and proteinuria.
    Zhou L; Chen X; Lu M; Wu Q; Yuan Q; Hu C; Miao J; Zhang Y; Li H; Hou FF; Nie J; Liu Y
    Kidney Int; 2019 Apr; 95(4):830-845. PubMed ID: 30770219
    [TBL] [Abstract][Full Text] [Related]  

  • 20. C-X-C Chemokine Receptor Type 4 Plays a Crucial Role in Mediating Oxidative Stress-Induced Podocyte Injury.
    Mo H; Wu Q; Miao J; Luo C; Hong X; Wang Y; Tang L; Hou FF; Liu Y; Zhou L
    Antioxid Redox Signal; 2017 Aug; 27(6):345-362. PubMed ID: 27960539
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.